| scholarly article | Q13442814 |
| P2093 | author name string | Raouf A Khalil | |
| Alain F Tanbe | |||
| P2860 | cites work | Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy | Q78117582 |
| Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs | Q78396702 | ||
| Angiotensin-(1-7) in normal and preeclamptic pregnancy | Q78568866 | ||
| Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors | Q80425329 | ||
| Serum levels of interleukin-6, interleukin-1beta and human chorionic gonadotropin in pre-eclamptic and normal pregnancy | Q80454204 | ||
| Recent patents on Rho signaling pathway as therapeutic target for cardiovascular diseases | Q80551190 | ||
| The immunohistochemical evaluation of VEGF in placenta biopsies of pregnancies complicated by preeclampsia | Q80821578 | ||
| Relationship between increased blood lead and pregnancy hypertension in women without occupational lead exposure in Tehran, Iran | Q80991877 | ||
| Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast | Q81086992 | ||
| Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies | Q81236313 | ||
| Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction | Q81305565 | ||
| Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression | Q81411178 | ||
| Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood | Q81432957 | ||
| Angiotensin II hypertension is attenuated in interleukin-6 knockout mice | Q81472565 | ||
| Dietary fiber, potassium, magnesium and calcium in relation to the risk of preeclampsia | Q81878607 | ||
| Antihypertensive drug therapy for mild to moderate hypertension during pregnancy | Q24246376 | ||
| Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups | Q24544895 | ||
| The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia | Q24795491 | ||
| Antioxidant therapy to prevent preeclampsia | Q28171421 | ||
| Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis | Q28191497 | ||
| Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review | Q28196410 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Aortic adaptation to pregnancy: elevated expression of matrix metalloproteinases-2 and -3 in rat gestation | Q28574980 | ||
| Impaired angiogenesis in SHR is associated with decreased KDR and MT1-MMP expression | Q28582505 | ||
| Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions | Q29547189 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor | Q30747560 | ||
| Endothelin and nitric oxide mediate reduced myogenic reactivity of small renal arteries from pregnant rats | Q31731441 | ||
| [Ca(2+)](i) signaling in renal arterial smooth muscle cells of pregnant rat is enhanced during inhibition of NOS. | Q31732247 | ||
| Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet | Q32071788 | ||
| Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation | Q33490821 | ||
| Endothelial cell responses to hypoxic stress | Q33535019 | ||
| Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. | Q33692449 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. | Q33940517 | ||
| Vascular function in preeclampsia. | Q33951685 | ||
| Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort | Q34081523 | ||
| Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia | Q34110398 | ||
| Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension | Q34293890 | ||
| Angiotensin and cytoskeletal proteins: role in vascular remodeling | Q34492824 | ||
| World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women | Q34565461 | ||
| Maternal vitamin D deficiency increases the risk of preeclampsia | Q34579840 | ||
| Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia | Q34656275 | ||
| 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system | Q34793842 | ||
| Nutrient involvement in preeclampsia | Q35121229 | ||
| The genetics of pre-eclampsia: a feto-placental or maternal problem? | Q35177399 | ||
| Placental trophoblast-derived factors diminish endothelial barrier function | Q47650864 | ||
| Characterization of endothelium- dependent relaxation in guinea pig basilar artery - effect of hypoxia and role of cytochrome P450 mono-oxygenase. | Q47694967 | ||
| Endothelial dysfunction in preeclampsia | Q47879591 | ||
| Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. | Q50514586 | ||
| Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. | Q50952787 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. | Q51139503 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. | Q51359651 | ||
| Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in pre-eclamptic women. | Q51436935 | ||
| Hypocalcemia and pregnancy-induced hypertension produced by low-calcium diet. | Q51594970 | ||
| Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. | Q51865183 | ||
| Environmental lead level and pregnancy-induced hypertension. | Q51965294 | ||
| Endothelial function in myometrial resistance arteries of normal pregnant women perfused with syncytiotrophoblast microvillous membranes. | Q52055001 | ||
| Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. | Q52170561 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| [The role of calcium in the regulation of normal vascular tone and in arterial hypertension] | Q53919958 | ||
| The preliminary characterization of a vasoactive circulating factor(s) in preeclampsia. | Q54010076 | ||
| Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. | Q54021736 | ||
| Rho A/Rho kinase: human umbilical artery mRNA expression in normal and pre eclamptic pregnancies and functional role in isoprostane-induced vasoconstriction. | Q54594222 | ||
| Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. | Q54661322 | ||
| Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. | Q54709411 | ||
| Soluble fms-like Tyrosine Kinase 1 | Q56619509 | ||
| Soluble Flt-1 as a diagnostic marker of pre-eclampsia | Q62504254 | ||
| Pre-eclampsia and trisomy 13 | Q67592481 | ||
| Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment | Q68053902 | ||
| Pre-eclampsia and trisomy 13: a possible association | Q69904752 | ||
| Protein kinase C in uterine and systemic arteries during ovarian cycle and pregnancy | Q70116950 | ||
| Chronic hypoxia selectively augments endothelium-dependent pulmonary arterial vasodilation | Q71465109 | ||
| Mammal-specific, ERK-dependent, caldesmon phosphorylation in smooth muscle. Quantitation using novel anti-phosphopeptide antibodies | Q73066673 | ||
| Ca(2+)-insensitive vascular protein kinase C during pregnancy and NOS inhibition | Q73087551 | ||
| Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery | Q73258662 | ||
| Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia | Q73399793 | ||
| Pregnancy-associated reduction in vascular protein kinase C activity rebounds during inhibition of NO synthesis | Q73426782 | ||
| Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation | Q73616010 | ||
| Phosphorylation of caldesmon by ERK MAP kinases in smooth muscle | Q73634448 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia | Q74226798 | ||
| Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy | Q74253964 | ||
| Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats | Q74518978 | ||
| Nitric oxide production with preeclampsia | Q74601245 | ||
| Circulating levels of immunoreactive cytokines in women with preeclampsia | Q77384781 | ||
| Peripheral blood mononuclear cells stimulate progesterone production by luteal cells derived from pregnant and non-pregnant women: possible involvement of interleukin-4 and interleukin-10 in corpus luteum function and differentiation | Q77519168 | ||
| Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression | Q77684136 | ||
| Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats | Q77755765 | ||
| Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats | Q77945719 | ||
| Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet | Q78009520 | ||
| Purification and characterization of a complex from placental syncytiotrophoblast microvillous membranes which inhibits the proliferation of human umbilical vein endothelial cells | Q78018453 | ||
| Trophoblast deportation and the maternal inflammatory response in pre-eclampsia | Q35190881 | ||
| Enhanced expression of Ang-(1-7) during pregnancy | Q35845564 | ||
| Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases. | Q35859073 | ||
| Abnormal placentation and the syndrome of preeclampsia | Q35941005 | ||
| Angiotensin II and vascular inflammation. | Q36140047 | ||
| Preeclampsia: recent insights | Q36288757 | ||
| Could antioxidant supplementation prevent pre-eclampsia? | Q36325124 | ||
| Fetal programming of hypertension | Q36341270 | ||
| Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. | Q36428553 | ||
| Calcium supplementation during pregnancy and lactation: effects on the mother and the fetus | Q36437354 | ||
| Neurovascular mechanisms of hypertension in pregnancy | Q36486193 | ||
| Intrauterine growth restriction: fetal programming of hypertension and kidney disease | Q36569856 | ||
| Diet during pregnancy and risk of preeclampsia or gestational hypertension | Q36867915 | ||
| Olmesartan improves endothelin-induced hypertension and oxidative stress in rats | Q36951733 | ||
| Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction | Q37022723 | ||
| Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. | Q37072792 | ||
| Endoglin in angiogenesis and vascular diseases | Q37088038 | ||
| Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia | Q37119326 | ||
| Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
| Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats | Q37449704 | ||
| Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways | Q38351435 | ||
| Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells | Q39371096 | ||
| Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover | Q40380110 | ||
| Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells | Q40418046 | ||
| Effects of placental proteases on maternal and fetal blood pressure in normal pregnancy and preeclampsia | Q41092408 | ||
| Mechanisms of smooth muscle contraction | Q41169589 | ||
| Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats | Q42515767 | ||
| Resistance artery smooth muscle function in pregnancy and preeclampsia | Q42516324 | ||
| Nitric oxide synthase activity in placentae from women with pre-eclampsia | Q42520050 | ||
| Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. | Q42757110 | ||
| Stabilization of hypoxia-inducible factor-1{alpha} by prostacyclin under prolonged hypoxia via reducing reactive oxygen species level in endothelial cells. | Q43413808 | ||
| Association of maternal endothelial dysfunction with preeclampsia | Q43553727 | ||
| Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. | Q43576536 | ||
| Regulation of prostacyclin synthesis by angiotensin II and TNF-alpha in vascular smooth muscle | Q43577316 | ||
| Elevated levels of S-nitrosoalbumin in preeclampsia plasma | Q43633772 | ||
| High intake of energy, sucrose, and polyunsaturated fatty acids is associated with increased risk of preeclampsia | Q43717221 | ||
| The role of endothelium-derived hyperpolarizing factor in the regulation of the uterine circulation in pregnant rats | Q43745798 | ||
| Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats | Q43888051 | ||
| Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia | Q44048792 | ||
| Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats | Q44130345 | ||
| Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure | Q44185600 | ||
| Reduced function of endothelial prostacyclin in human omental resistance arteries in pre-eclampsia | Q44218040 | ||
| Pulmonary vascular endothelial growth factor and nitric oxide interaction during total cardiopulmonary bypass in neonatal pigs | Q44456864 | ||
| Tumor necrosis factor alpha in the bovine oviduct during the estrous cycle: messenger RNA expression and effect on secretion of prostaglandins, endothelin-1, and angiotensin II. | Q44475138 | ||
| Pre-eclampsia (EPH-gestosis)-induced decrease of MMP-s content in the umbilical cord artery | Q44555376 | ||
| Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats | Q44715072 | ||
| Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia | Q44897228 | ||
| The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood | Q44929427 | ||
| Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts | Q45008785 | ||
| Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta | Q45061635 | ||
| Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors | Q45102837 | ||
| Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction | Q45159052 | ||
| Effects of vasoactive agents on intracellular calcium and force in myometrial and subcutaneous resistance arteries isolated from preeclamptic, pregnant, and nonpregnant woman | Q45254319 | ||
| Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. | Q45256231 | ||
| Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? | Q46342132 | ||
| Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia | Q46440312 | ||
| Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition | Q46454719 | ||
| Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia. | Q46475774 | ||
| Angiotensin-converting enzyme inhibitors reveal non-NO-, non-prostacycline-mediated endothelium-dependent relaxation in internal thoracic artery of hypertensive patients | Q46590537 | ||
| Mechanisms of endothelin-1-induced contraction in pulmonary arteries from chronically hypoxic rats | Q46697023 | ||
| Evidence that inward rectifier K+ channels mediate relaxation by the PGI2 receptor agonist cicaprost via a cyclic AMP-independent mechanism | Q46719781 | ||
| Angiotensin II infusion alters vascular function in mouse resistance vessels: roles of O and endothelium | Q46844588 | ||
| Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies | Q46878600 | ||
| Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites | Q46886600 | ||
| The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species | Q46966458 | ||
| Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies | Q46987465 | ||
| Genetic and environmental factors associated with the development of hypertension in pregnancy | Q47605160 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 60-75 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Current Bioactive Compounds | Q15765834 |
| P1476 | title | Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy | |
| P478 | volume | 6 |
| Q36339474 | Adaptive increases in expression and vasodilator activity of estrogen receptor subtypes in a blood vessel-specific pattern during pregnancy |
| Q37973600 | Antiangiogenic-induced hypertension: the molecular basis of signaling network |
| Q50768904 | Association between specific periodontal pathogens, Toll-like receptor-4, and nuclear factor-κB expression in placental tissues of pre-eclamptic women with periodontitis. |
| Q28083815 | Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia |
| Q93074775 | Intrauterine Growth Restriction and Hyperoxia as a Cause of White Matter Injury |
| Q46342648 | Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia |
| Q37136212 | Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia |
| Q58589187 | Molecular Determinants of Microvascular Dysfunction in Hypertensive Pregnancy and Preeclampsia |
| Q48874599 | Novel thromboxane A2 analog-induced IUGR mouse model. |
| Q92895782 | Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period |
| Q35624157 | Perinatal infection, inflammation, and retinopathy of prematurity |
| Q92994624 | Preeclampsia link to gestational hypoxia |
| Q34205668 | Pregnancy disorders appear to modify the risk for retinopathy of prematurity associated with neonatal hyperoxemia and bacteremia |
| Q26828020 | Role of endothelin in uteroplacental circulation and fetal vascular function |
Search more.